Table 6.
Screening for and management of risk factors.
| Clinical activity | Value | Median, SD, range | ICC |
|---|---|---|---|
| (where applicable) | |||
| BP result documented, % | 98 | ||
| No. of BP readings | 15 | 15, 9, 0–24 | 0.06424 (0.042231, 0.086249) |
|
| |||
| Mean BP; | |||
| Systolic mmHg | 134 | 135, 12, 102–165 | −0.14068 (−0.187383, −0.093977) |
| Within systolic BP targets of ≤130 | 31.0 | 0.00 (−0.003311, 0.003311) | |
| Diastolic, mmHg | 74 | 74, 7, 54–94 | 0.03471 (0.020974, 0.048446) |
| Within diastolic BP targets of ≤80 | 84.5 | 0.00 (−0.003311, 0.003311) | |
| Lipid profile obtained once, % | 97 | 0.040813 (0.025322, 0.056304) | |
| Mean total cholesterol | 4.58 | 4.49, 0.99, 2.43–7.98 | −0.06611 (−0.084751, −0.047469) |
|
| |||
| Medications to prevent complications | % Patients | ||
| On ACE I | 40.0 | −0.02382 (−0.028101, −0.019539) | |
| On lipid lowering medications | 39.2 | 0.38283 (0.306461, 0.459199) | |
| On ASA | 22.7 | 0.045959 (0.029007, 0.062911) | |